These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation. Ferrajoli A; Talpaz M; Kurzrock R; Harris D; Van Q; Estey EH; Estrov Z Leuk Lymphoma; 1998 Jul; 30(3-4):279-92. PubMed ID: 9713960 [TBL] [Abstract][Full Text] [Related]
44. Myelodysplastic syndrome (MDS)-associated inhibitory activity on haematopoietic progenitor cells: contribution of monocyte-derived lipid containing macrophages (MDLM). Ohmori M; Ueda Y; Masutani H; Hirama T; Anzai N; Yoshida Y; Okuma M Br J Haematol; 1992 May; 81(1):67-72. PubMed ID: 1520627 [TBL] [Abstract][Full Text] [Related]
45. [Clonal culture of hematopoietic cells in patients with the myelodysplastic syndrome]. Jelínek J; Neuwirt J; Neuwirtová R Vnitr Lek; 1986 Mar; 32(3):222-7. PubMed ID: 3962203 [No Abstract] [Full Text] [Related]
46. Detection of myeloid precursors (granulocyte/macrophage colony forming units) in the bone marrow adjacent to rheumatoid arthritis joints. Kotake S; Higaki M; Sato K; Himeno S; Morita H; Kim KJ; Nara N; Miyasaka N; Nishioka K; Kashiwazaki S J Rheumatol; 1992 Oct; 19(10):1511-6. PubMed ID: 1464860 [TBL] [Abstract][Full Text] [Related]
47. Functional studies of bone marrow haemopoietic and stromal cells in the myelodysplastic syndrome (MDS). Coutinho LH; Geary CG; Chang J; Harrison C; Testa NG Br J Haematol; 1990 May; 75(1):16-25. PubMed ID: 2375919 [TBL] [Abstract][Full Text] [Related]
48. In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor. Mayani H; Baines P; Bowen DT; Jacobs A Leukemia; 1989 Jan; 3(1):29-32. PubMed ID: 2642575 [TBL] [Abstract][Full Text] [Related]
49. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes]. García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051 [TBL] [Abstract][Full Text] [Related]
50. Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis. Machherndl-Spandl S; Sega W; Bösmüller H; Germing U; Gruber Ch; Nachtkamp K; Reinecke P; Sperr WR; Wimazal F; Müllauer L; Sotlar K; Horny HP; Tüchler H; Valent P; Krieger O Ann Hematol; 2014 Jan; 93(1):57-64. PubMed ID: 24241126 [TBL] [Abstract][Full Text] [Related]
51. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome. Zheng Z; Qianqiao Z; Qi H; Feng X; Chunkang C; Xiao L Exp Hematol; 2010 Aug; 38(8):677-84. PubMed ID: 20394797 [TBL] [Abstract][Full Text] [Related]
52. Ineffective hemopoiesis in the myelodysplastic syndromes (MDS) as studied by daily in situ observation of colony-cluster formation. Ohmori M; Ohmori S; Ueda Y; Yoshida Y; Okuma M Int J Cell Cloning; 1991 Sep; 9(5):521-30. PubMed ID: 1955740 [TBL] [Abstract][Full Text] [Related]
53. Alterations in CFU-GM growth in preleukaemic and leukaemic AKR/J mice. Alonso MC; Torres A; Solana R; Manzanares MR; Garcia-Castellano JM; Peña J Folia Biol (Praha); 1985; 31(3):193-9. PubMed ID: 4018306 [TBL] [Abstract][Full Text] [Related]
54. In vitro functions of stromal cells from human and mouse bone marrow. Zipori D; Reichman N; Arcavi L; Shtalrid M; Berrebi A; Resnitzky P Exp Hematol; 1985 Aug; 13(7):603-9. PubMed ID: 4029289 [TBL] [Abstract][Full Text] [Related]
55. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors. Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928 [TBL] [Abstract][Full Text] [Related]
56. Colony-forming unit cell (CFU-C) assays at diagnosis: CFU-G/M cluster predicts overall survival in myelodysplastic syndrome patients independently of IPSS-R. Li B; Liu J; Qu S; Gale RP; Song Z; Xing R; Liu J; Ren Y; Xu Z; Qin T; Zhang Y; Fang L; Zhang H; Pan L; Hu N; Cai W; Zhang P; Huang G; Xiao Z Oncotarget; 2016 Oct; 7(42):68023-68032. PubMed ID: 27655727 [TBL] [Abstract][Full Text] [Related]
57. Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor. Carlo-Stella C; Cazzola M; Bergamaschi G; Bernasconi P; Dezza L; Invernizzi R; Pedrazzoli P Leukemia; 1989 May; 3(5):363-6. PubMed ID: 2654496 [TBL] [Abstract][Full Text] [Related]
58. Enrichment of haemopoietic progenitor cells from the marrow of patients with myelodysplasia. Baines P; Masters GS; Lush C; Jacobs A Br J Haematol; 1988 Feb; 68(2):159-64. PubMed ID: 3280003 [TBL] [Abstract][Full Text] [Related]
59. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes. Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505 [TBL] [Abstract][Full Text] [Related]
60. Megakaryocyte colony formation by bone marrow progenitors in myelodysplastic syndromes. Juvonen E; Partanen S; Knuutila S; Ruutu T Br J Haematol; 1986 Jun; 63(2):331-4. PubMed ID: 3718873 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]